Which institute received permission to carry out Phase III randomized, Double-blind, Placebo-controlled trial of efficacy, safety, and tolerability of antiviral drugs Umifenovir?
5 604 5ef5a3e0e6dbc50ad1808dcf
Q:
Which institute received permission to carry out Phase III randomized, Double-blind, Placebo-controlled trial of efficacy, safety, and tolerability of antiviral drugs Umifenovir?
- 1Employees' state Insurance Corporationfalse
- 2CSIR-Central Drug Research Institutetrue
- 3The Indian Council of Medical Researchfalse
- 4All India Institute Of Medical Sciencefalse
- Show Answer
- Workspace
- Discuss